KunWha Pharmaceutical Co., Ltd. (KOSE:A002250) has been chosen as the preferred bidder to buy Hanwha Corp.'s (KOSE:A000880) Dream Pharma Corp., according to sources on July 3, 2014. Kunwha Pharmaceuticals will exercise its right to enter into exclusive negotiations for two weeks.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26,400 KRW | +0.38% | +0.19% | +2.52% |
Jun. 07 | U.S. trade panel votes to proceed with solar panel tariff probe | RE |
Jun. 04 | First Solar, Qcells to be US government's preferred green-label panel vendors | RE |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.52% | 1.42B | |
+3.32% | 72.17B | |
+5.64% | 49.68B | |
+19.77% | 45.68B | |
+11.53% | 41.53B | |
+20.70% | 38.33B | |
+19.85% | 33.98B | |
-4.15% | 27.98B | |
+28.96% | 26.67B | |
-10.67% | 26.66B |
- Stock Market
- Equities
- A000880 Stock
- News Hanwha Corporation
- Kunwha Reportedly Named As Preferred Bidder For Dream Pharma